The gene expression profiling of the extramammary Paget's disease, identification of a surface marker and establishment of a cell line
Project/Area Number |
22791055
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Single-year Grants |
Research Field |
Dermatology
|
Research Institution | Chiba University |
Principal Investigator |
TOGAWA Yaei 千葉大学, 大学院・医学研究院, 助教 (90361427)
|
Project Period (FY) |
2010 – 2011
|
Project Status |
Completed (Fiscal Year 2011)
|
Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2011: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2010: ¥2,990,000 (Direct Cost: ¥2,300,000、Indirect Cost: ¥690,000)
|
Keywords | 皮膚腫瘍学 / 皮膚科学 / 皮膚悪性腫瘍 / 乳房外パジェット病 / 遺伝子プロファイル |
Research Abstract |
We reported the efficacy for an observation technique of the Paget's cell with a fluorescence microscope in order to identify advanced lesion and small invasive lesion of extramammary Paget's disease. It was the technique based on histological staining of CEA (Paget's cell), D2-40 (lymph vessel) and Hoechst (nucleus). We also reported the first case of 68-year-old Japanese woman with metastatic HER2-positive extramammary Paget's disease that showed the validity of trastuzumab monotherapy. Trastuzumab has few side effects and is well tolerated for elderly patients. It may become a new choice of the adjubant therapy of this disease.
|
Report
(3 results)
Research Products
(5 results)